ISPOR 2016 EU – Value Added Medicines

18 November 2016

Policy, Report

Healthcare System Inefficiencies Related To Medicines: Any Potential Room For […]

Market Review – European Generic Medicines Markets 2016

10 November 2016

Report

Simon-Kucher. Policy Requirements for a Sustainable Biosimilar Market (September 2016)

19 September 2016

Report

IMS – The Impact of Biosimilar Competition (2016)

1 June 2016

Report

Value Added Medicines: Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

31 May 2016

Policy, Report

IMS Institute – Biosimilar Report

31 March 2016

Report